新西兰将于2026年开始路边药物测试, 但批评者说,他们检测到毒品, New Zealand to start roadside drug tests in 2026, but critics say they detect drugs, not impairment, risking unfair penalties.

新西兰计划利用大麻、甲基安非他明、甲基安非他明、甲基安非他明和可卡因的唾液测试,在2026年年中启动路边药物测试,但专家们警告说,这一方法存在缺陷。 New Zealand plans to launch roadside drug testing in mid-2026 using saliva tests for cannabis, methamphetamine, MDMA, and cocaine, but experts warn the approach is flawed. 批评者认为，这些检测检测的是药物存在，而非影响，可能会惩罚非危险驾驶者，包括常规大麻使用者和服用处方药如右旋安非他命者。 Critics say the tests detect drug presence, not impairment, potentially penalizing users who aren’t dangerous drivers, including regular cannabis users and those on prescribed medications like dexamphetamine. 几乎没有证据表明该项目能减少事故发生率，而像苯二氮卓类和阿片类药物这样带来更高风险的合法药物也未被纳入其中。 There’s little evidence the program reduces crashes, and legal drugs like benzodiazepines and opioids, which pose greater crash risks, are not included. 令人关注的问题还包括侵犯隐私和假阳性,专家们敦促把重点放在实际损害上,而不是仅仅药物检测。 Concerns also include privacy violations and false positives, with experts urging a focus on actual impairment rather than drug detection alone.